Evidence map›Paper›PMID 35040152›Full record

ReviewImmunological reviews2022

Regulatory strategies limiting endosomal Toll-like receptor activation in B cells.

Mridu Acharya, Shaun W Jackson

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mridu AcharyaDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.
Shaun W JacksonDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.ORCID 0000-0002-7024-5252
University of Washington · US

Funding

RESEARCH TRAINING IN RHEUMATOLOGYT32AR007108 · NIAMS · UNIVERSITY OF WASHINGTON · PI Shaun Jackson, Tomas M Mustelin · 1986 to 2026
$6.6M
Mechanistic insights into systemic lupus erythematosus (SLE) pathogenesis from inborn errors of immunityR01AR073938 · NIAMS · SEATTLE CHILDREN'S HOSPITAL · PI Shaun William Jackson · 2019 to 2026
$4.0M
Manipulating alpha(v) integrins on B cells to promote lung-resident B cell responsesR01AI151167 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Mridu Acharya · 2020 to 2026
$3.3M
Impact of Loss-of-function NADPH Oxidase Variants on B-Cell Activation in SLER01AR075813 · NIAMS · SEATTLE CHILDREN'S HOSPITAL · PI JACKSON, SHAUN WILLIAM · 2021 to 2025
$2.8M
B cell-intrinsic roles for STAT1 gain-of-function mutations in humoral autoimmunityR03AI139716 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI JACKSON, SHAUN WILLIAM · 2018 to 2019
$188k
NIAID NIH HHS R01 AI151167NIAID NIH HHS R03 AI139716NIAMS NIH HHS R01 AR073938NIAMS NIH HHS R01 AR075813NIAMS NIH HHS T32 AR007108
6 · The paper itself

Abstract

The recognition of pathogen-associated nucleic acid (NA) promotes effective immunity against invading pathogens. However, endosomal Toll-like receptor (TLR) activation by self-NA also underlies the pathogenesis of systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). For this reason, the activation thresholds of NA-sensing TLRs must be tightly regulated to balance protective and pathogenic immune responses. In this study, we will provide an overview of the evolutionary mechanisms designed to limit the aberrant activation of endosomal TLRs by self-ligands, focusing on four broad strategies. These include the following: 1) the production of nucleases able to degrade self-DNA and RNA; 2) the cell-specific regulation of endosomal TLR expression; 3) the spatial and temporal control of TLR positioning at a sub-cellular level; and 4) the modulation of downstream TLR signaling cascades. Given the critical role of B cells in lupus pathogenesis, where possible, we will describe evidence for B cell-specific induction of these regulatory mechanisms. We will also highlight our own work showing how modulation of B cell endolysosomal flux tunes NA-sensing TLR activation signals. In the face of inevitable generation of self-NA during normal cellular turnover, these parallel mechanisms are vital to protect against pathogenic inflammation.

Indexed as

B-LymphocytesToll-Like ReceptorsEndosomesHumansLupus Erythematosus, SystemicSignal TransductionToll-Like ReceptorsB cellsendolysosomal traffickingnon-canonical autophagysystemic lupus erythematosusToll-like receptors

Identifiers

PMID35040152
PMCPMC8986562
OpenAlexW4206696625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.